- Home
- DHY vs OPRX Comparison
DHY vs OPRX Comparison
Compare DHY & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHY
- OPRX
- Stock Information
- Founded
- DHY 1998
- OPRX 2006
- Country
- DHY United States
- OPRX United States
- Employees
- DHY N/A
- OPRX N/A
- Industry
- DHY Finance/Investors Services
- OPRX Business Services
- Sector
- DHY Finance
- OPRX Consumer Discretionary
- Exchange
- DHY Nasdaq
- OPRX Nasdaq
- Market Cap
- DHY 211.3M
- OPRX 234.9M
- IPO Year
- DHY N/A
- OPRX N/A
- Fundamental
- Price
- DHY $2.12
- OPRX $14.35
- Analyst Decision
- DHY
- OPRX Buy
- Analyst Count
- DHY 0
- OPRX 8
- Target Price
- DHY N/A
- OPRX $10.81
- AVG Volume (30 Days)
- DHY 569.1K
- OPRX 200.6K
- Earning Date
- DHY 01-01-0001
- OPRX 08-07-2025
- Dividend Yield
- DHY 9.10%
- OPRX N/A
- EPS Growth
- DHY N/A
- OPRX N/A
- EPS
- DHY N/A
- OPRX N/A
- Revenue
- DHY N/A
- OPRX $94,365,000.00
- Revenue This Year
- DHY N/A
- OPRX $14.44
- Revenue Next Year
- DHY N/A
- OPRX $10.63
- P/E Ratio
- DHY N/A
- OPRX N/A
- Revenue Growth
- DHY N/A
- OPRX 20.66
- 52 Week Low
- DHY $1.77
- OPRX $3.78
- 52 Week High
- DHY $2.08
- OPRX $15.71
- Technical
- Relative Strength Index (RSI)
- DHY 49.44
- OPRX 59.59
- Support Level
- DHY $2.10
- OPRX $12.71
- Resistance Level
- DHY $2.00
- OPRX $14.96
- Average True Range (ATR)
- DHY 0.02
- OPRX 0.86
- MACD
- DHY -0.00
- OPRX 0.05
- Stochastic Oscillator
- DHY 30.00
- OPRX 77.57
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.